Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04270409 |
|---|---|
| Brief Title: | A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma |
| First Submitted : | February 13, 2020 |
| First Submitted that Met QC Criteria : | February 13, 2020 |
| First Posted : | February 17, 2020 |
| Last Update Submitted that Met QC Criteria : | March 7, 2024 |
| Last Update Posted : | March 8, 2024 |